Sustained release
A format-specific objective that must be confirmed through analytical and product development.
Delivery technology
Transdermal Patches
Sustained-delivery concepts that can bypass gastrointestinal absorption.
Why it matters
Skin permeation, adhesion, dose capacity, irritation and release specifications must be established for each program.
Sustained-delivery concepts that can bypass gastrointestinal absorption.
Availability, specifications and regulatory status vary by market, formulation and stage of development.
- Scientific rationale is distinguished from demonstrated outcomes.
- Capabilities are mapped to application, format and regulatory context.
- Confidential depth is available through qualified access rather than exposed publicly.
Designed as a platform
What makes this approach different
ChronoSense® connects the biological hypothesis to delivery, evidence, data and a controlled route to market.
All-day convenience
Designed around user context without substituting convenience for evidence.
Bypasses the gastrointestinal tract
Integrated with quality, manufacturing and claims planning from the start.
A disciplined pathway
From insight to accountable action
The platform is designed to move through explicit stages, with evidence and access appropriate to each one.
1
Opportunity definition
Specify dose range, application, use time, territory and desired exposure.
2
Formulation feasibility
Evaluate material compatibility, stability and release or uptake behavior.
3
Validation
Establish specifications, safety and fit-for-purpose evidence.
4
Commercial transfer
Connect documentation, manufacturing, supply and licensing terms.
Next step
Discuss a transdermal patches program.
Share your application, market, timing and evidence needs so the right technical pathway can be assessed.